Welcome to our dedicated page for Dentsply Sirona news (Ticker: XRAY), a resource for investors and traders seeking the latest updates and insights on Dentsply Sirona stock.
DENTSPLY SIRONA Inc. develops, manufactures and markets professional dental products, dental technologies, oral health products and other consumable medical devices under a broad brand portfolio. News for XRAY commonly covers quarterly results, outlook updates, restructuring actions, capital allocation, debt reduction, share repurchases and changes to distribution relationships for dental equipment and connected technology solutions.
Company updates also focus on digital dentistry and imaging products, including CEREC systems, intraoral scanning, CBCT imaging, DS Core, Smart View - Detect and dental-dedicated MRI work with Siemens Healthineers. Additional product news includes Surity urinary incontinence devices from Wellspect HealthCare, along with regulatory clearances, CE markings, commercial launches, board changes and investor conference participation.
Dentsply Sirona (Nasdaq: XRAY) reported a strong third-quarter performance with net sales reaching $1,069 million, a 19.4% increase from last year. GAAP EPS rose to $0.47 from $0.25 in 2020, while Non-GAAP EPS slightly increased to $0.68. The company also raised its FY2021 revenue outlook, expecting $4.25 billion to $4.3 billion, up 27-30% year-over-year. Notably, organic sales grew over 21%.
Dentsply Sirona announced an investor conference call scheduled for November 4, 2021, at 8:30 am ET to discuss its financial results. The presentation related to the call will be available on the investor section of the company’s website. Participants can join the call by dialing +1-877-370-7637 for domestic or +1-629-228-0723 for international calls. A replay will be accessible for one week post-call. Dentsply Sirona is the largest manufacturer of professional dental products and is listed on Nasdaq under the symbol XRAY.
Dentsply Sirona, the largest dental product manufacturer, announced a partnership with Smile Train, enhancing cleft care access globally. This five-year collaboration aims to provide free cleft surgeries and essential care for over 1.5 million children in more than 90 countries. Key initiatives include supporting global treatment standards, leveraging digital technologies, and offering training programs for local healthcare professionals. The partnership seeks to empower communities and ensure a lasting impact on cleft care.
Dentsply Sirona introduces a revamped Implants business, launching DS Implants that integrates brands like Simplant and MIS. The initiative presents three digital workflows designed to enhance implantology practices: Single Tooth, Partial Multiple Tooth Replacement, and Full Arch Signature Workflows, which aim to boost efficiency and patient satisfaction. A highlight is the DS PrimeTaper, a self-tapping implant with a tapered design for easier insertion and long-term bone stability. The company emphasizes a global clinical education program to support digital implant skills development among clinicians.
Summary not available.
Dentsply Sirona (Nasdaq: XRAY) announced its annual clinical education event, Dentsply Sirona World (DS World) 2021, scheduled for September 23-25, 2021. This event will offer over 100 training programs and new product launches, featuring prominent speakers like Drs. Shivi Gupta and Dan Butterman. The hybrid format allows participants to join onsite in Las Vegas or virtually. Investors can access live webcasts of key sessions, including a dedicated investment community session on September 23.
Dentsply Sirona (Nasdaq: XRAY), a leading dental solutions provider, will participate in the Baird 2021 Global Healthcare Conference. CFO Jorge Gomez is scheduled for a fireside chat on September 15 at 2:35 PM ET. Investors can access a live webcast through the Investor section of the Dentsply Sirona website. A replay will also be available after the event. Established as a major manufacturer of dental products, Dentsply Sirona focuses on innovative solutions to enhance patient care and dentistry quality.
DENTSPLY SIRONA (XRAY) reported second-quarter 2021 revenues of $1,067 million, a substantial 117.3% increase from $491 million in Q2 2020. GAAP EPS stood at $0.45 compared to a loss of ($0.44) in 2020, while Non-GAAP EPS rose to $0.71 from a loss of ($0.18). Operating income also improved significantly, reaching $155 million from a loss of ($104 million). The company reaffirmed its FY21 Non-GAAP EPS outlook at $2.75 to $2.90 amidst a recovering dental market.
Dentsply Sirona announced an investor conference call on August 5, 2021, at 8:30 am ET to review its financial results. The call will be accessible via a live webcast on the Company’s investor website. Participants can dial +1-877-370-7637 for domestic calls or +1-629-228-0723 internationally, using conference ID # 4184820. A replay will be available for one week post-call. Dentsply Sirona is the world's largest manufacturer of dental products, and its stock is traded on Nasdaq under the symbol XRAY.
Dentsply Sirona (Nasdaq: XRAY) has acquired Propel Orthodontics for $131 million in cash. The acquisition includes Propel's VPro device and the Fastrack Mobile App, enhancing Dentsply's position in the growing clear aligner market. Propel Orthodontics is recognized for its innovative orthodontic devices and offers solutions for both in-office and at-home use. This strategic move aims to complement Dentsply's existing Byte® and SureSmile® businesses, reinforcing its commitment to advancing patient care in dentistry.